We unearthed that once-weekly dulaglutide decreased HbA1c level in clients with advanced-stage diabetic nephropathy after altering from once-daily liraglutide
We unearthed that once-weekly dulaglutide decreased HbA1c level in clients with advanced-stage diabetic nephropathy after altering from once-daily liraglutide But once-weekly dulaglutide failed to impact UACR and/or annual change of eGFR, nor made it happen show any undesireable effects on the clients. Dulaglutide is a long-acting GLP-1 receptor agonist with a half-life of approximately 5 […]
